About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Nicolet Law Files First Lawsuit in the Nation Over Salmonella Javiana Outbreak Linked to Contaminated Jalapeños
Via Law Firm Newswire
Topics Economy Lawsuit Product Recall
Exposures Financial Legal Product Safety
News headline image
Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule ↗
Via Benzinga
Exposures Product Safety
News headline image
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles ↗
Via MarketBeat
Tickers NRXP
Exposures Product Safety
News headline image
Ulcerative Colitis Market: Size, Trends, and Strategic Outlook 2026-2033 ↗
Via Talk Markets
Topics Economy
Exposures Product Safety Supply Chain
Entera Bio (NASDAQ:ENTX) Slides on Wider Q2 Loss Despite FDA Phase 3 Alignment and $275M Cash Raise ↗
Via Chartmill
Tickers ENTX
Exposures Product Safety
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
Via Investor Brand Network
Tickers TNXP
Exposures Product Safety
News headline image
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
Via Newsfile
Topics Intellectual Property
Tickers ASX:COH COCH
Exposures Intellectual Property Product Safety
News headline image
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
Via Benzinga
Exposures Product Safety
News headline image
EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Trial ↗
Via Benzinga
Exposures Product Safety
News headline image
Future Outlook of the Ovarian Cancer Drugs Market: Size, Trends & Growth ↗
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
News headline image
Global Precision Medicine Market: Size, Trends, Drivers, and Forecast 2026-2033 ↗
Via Talk Markets
Topics Artificial Intelligence
Tickers PFE
Exposures Artificial Intelligence Product Safety
News headline image
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision? ↗
Via The Motley Fool
Tickers KDP PM TPB
Exposures Product Safety
News headline image
MDLN Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Teleflex Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers TFX
Exposures Financial Product Safety
News headline image
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
Via NewMediaWire
Tickers MDLN
Exposures Product Safety
News headline image
Takeda (TAK) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers TAK
Exposures Financial Product Safety
News headline image
Glaukos (GKOS) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers GKOS
Exposures Financial Product Safety
News headline image
uniQure (QURE) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers QURE
Exposures Financial Product Safety
News headline image
Boston Scientific (BSX) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Tickers BSX
Exposures Financial Product Safety
News headline image
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem ↗
Via The Motley Fool
Tickers LLY NVO
Exposures Product Safety
News headline image
Artivion Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers AORT
Exposures Financial Product Safety
News headline image
Houston Clinic Says Published Research Does Not Establish How Long Knee Stem Cell Therapy Lasts
Via Press Advantage
Exposures Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth
Via StockStory
Tickers NTRA
Exposures Product Safety
NetworkNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones
Via Investor Brand Network
Tickers RGNT
Exposures Product Safety
News headline image
Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Via Newsfile
Topics Lawsuit
Tickers CAPR SAP
Exposures Financial Legal Product Safety
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approach to Neurological Health
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)Advances Two-Pronged Approach to Neurological Health
Via Investor Brand Network
Tickers CSE:QNTM QNTM
Exposures Product Safety
News headline image
Trevi Therapeutics Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
Tickers TRVI
Exposures Financial Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.